Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study

INTRODUCTION: The aim of this study was to examine ranibizumab treatment patterns in “real-world” practice and clinical settings, as well as to assess quality of life outcomes over a 24-month period. MATERIALS AND METHODS: This was a prospective, observational, multicenter, open-label study of 0.5 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakic, Jean-Marie, Leys, Anita, Brié, Heidi, Denhaerynck, Kris, Pacheco, Christy, Vancayzeele, Stefaan, Hermans, Christine, MacDonald, Karen, Abraham, Ivo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788820/
https://www.ncbi.nlm.nih.gov/pubmed/24092964
http://dx.doi.org/10.2147/OPTH.S49385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788820/
https://www.ncbi.nlm.nih.gov/pubmed/24092964
http://dx.doi.org/10.2147/OPTH.S49385

Ejemplares similares